RxDoctor Payments Data

Alan Edwards, MD

Internal Medicine · Franklin, VANPI 1114038205

Payments from drug & device makers

$1,152in general payments, 2019–2025

Across 68 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$568
  • Novartis$135
  • Corium, LLC$69
  • AbbVie$57
  • Boehringer Ingelheim$45
  • Astellas Pharma US Inc$32
  • plus $247 from 13 others

What the payments were for

  • Food & beverage$1,13999%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,152 in reported general payments places this provider in the 75th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$256,725
Medicare patients
352
Services billed
2,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban367$271,665
JanuviaSitagliptin Phosphate208$191,619
JardianceEmpagliflozin199$171,944
OzempicSemaglutide103$116,020
EntrestoSacubitril/Valsartan93$77,366
FarxigaDapagliflozin Propanediol109$75,692
XareltoRivaroxaban103$67,465
Breztri AerosphereBudesonide/Glycopyr/Formoterol49$36,481
TradjentaLinagliptin36$35,839
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog27$32,457
Tresiba Flextouch U-100Insulin Degludec41$26,592
JanumetSitagliptin Phos/Metformin Hcl23$19,417
SymbicortBudesonide/Formoterol Fumarate56$17,791
LinzessLinaclotide24$13,727
Janumet XrSitagliptin Phos/Metformin Hcl24$9,510

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$271,665367 claims
MerckJanuvia, Janumet, Janumet Xr$17$220,546255 claims
Boehringer IngelheimJardiance, Tradjenta$45$207,784235 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$568$129,965214 claims
Novo NordiskOzempic$29$116,020103 claims
NovartisEntresto$135$77,36693 claims
Johnson & JohnsonXarelto$25$67,465103 claims
AbbVieLinzess$57$13,72724 claims
Kowa Pharmaceuticals America, Inc.Livalo$15$9,02612 claims
Esperion Therapeutics, Inc.Nexletol$23$7,48711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,724 internal medicine providers in Virginia.

Other internal medicine in Franklin

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →